Evidence map›Paper›PMID 36709375›Full record

ArticleScientific reports2023

Usefulness of pyruvate dehydrogenase-E1α expression to determine SUVmax cut-off value of [

Ryuichi Ito, Masakazu Yashiro, Takuma Tsukioka, Nobuhiro Izumi, Hiroaki Komatsu, Hidetoshi Inoue, Noritoshi Nishiyama

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. SyntheticRSC medicinal chemistry · 2024
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution.

Ryuichi ItoDepartment of Thoracic Surgery, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Masakazu YashiroMolecular Oncology and Therapeutics, Osaka Metropolitan University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan. m9312510@med.osaka-cu.ac.jp.
Takuma TsukiokaDepartment of Thoracic Surgery, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Nobuhiro IzumiDepartment of Thoracic Surgery, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Hiroaki KomatsuDepartment of Thoracic Surgery, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Hidetoshi InoueDepartment of Thoracic Surgery, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Noritoshi NishiyamaDepartment of Thoracic Surgery, Osaka Metropolitan University, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Osaka Metropolitan University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A more accurate cut-off value of maximum standardized uptake value (SUVmax) in [

Indexed as

Fluorodeoxyglucose F18Lung NeoplasmsHumansLymphatic MetastasisLymph NodesOxidoreductasesPositron Emission Tomography Computed TomographyPyruvatesRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18OxidoreductasesPyruvatesRadiopharmaceuticals

Identifiers

PMID36709375
PMCPMC9884208
OpenAlexW4318338059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.